Official journal of the Slovak Society of Cardiology,
Slovak Society of Hypertension and Slovak Association for Cardiac Arrhythmias

Cardiology Letters 2022, 31(5):320-328

Cardiac resynchronization therapy

Kerekanič M
I. kardiologickej klinika UPJŠ LF a VÚSCH, a. s., Košice, Slovenská republika

Chronic heart failure (CHF) is a real public epidemic and a leading cause of morbidity and mortality of patients worldwide. Despite modern pharmacological therapy, prognosis of CHF is poor. Cardiac resynchronization therapy (CRT) has become an important therapy for selected patients with CHF, left ventricular systolic dysfunction and electromechanical dyssynchrony. Clinical studies have demonstrated that CRT reduces morbidity and mortality of patients due to CHF. The aim of the present work is a summary of current recommendations for CRT in therapy of CHF.

Keywords: chronic heart failure; cardiac dyssynchrony; cardiac resynchronization therapy

Published: May 1, 2022  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kerekanič M. Cardiac resynchronization therapy. Cardiology Letters. 2022;31(5-6):320-328.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). With the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J 2021;42:3599-3726. Go to original source...
    2. Myerburg RJ, Gelband H, Nilsson K, et al. The role of canine superficial ventricular muscle fibers in endocardial impulse distribution. Circ Res 1978;42:27-35. Go to original source...
    3. Durrer D, van Dam RT, Freud GE, et al. Total excitation of the isolated human heart. Circulation 1970;41:889-912. Go to original source...
    4. Spach MS, Miller WT, Geselowitz DB, et al. The discontinuous nature of propagation in normal canine cardiac muscle. Evidence for recurrent discontinuities of intracellular resistance that affect the membrane currents. Circ RES 1981;48:39-54. Go to original source...
    5. Eriksson P, Hansson PO, Eriksson H, et al. Bundle-branch block in a general male population: the study of men born 1913. Circulation 1998;98:2494-2500. Go to original source...
    6. Strauss DG, Selvester RH, Wagner GS, Defining left bundle branch block in the era of cardiac resynchronization therapy. Am J Cadiol 2011;109:927-934. Go to original source...
    7. Nguyên UC, Verzaal NJ, van Nieuwenhoven FA, et al. Pathobiology of cardiac dyssynchrony and resynchronization therapy. Europace 2018;20:1898-1909. Go to original source...
    8. Wyman BT, Hunter WC, Prinzen FW, et al. Effect of single and biventricular pacing on temporal and spatial dynamics of ventricular contraction. Am J Physiol 2002;282:H372-379. Go to original source...
    9. A Wang NC, Adelstein EC, Singh M, et al. Left bundle branch block-associated cardiomyopathies and early cardiac resynchronization therapy: conceptualizing a tailored approach. J Am Coll Cardiol 2018;71:1943-1944. Go to original source...
    10. Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC). With the special contribution of the European Heart Rhythm Association (EHRA). Eur Heart J 2021;42:34273520. Go to original source...
    11. Rao RK, Kumar UN, Schafer J, et al. Reduced ventricular volumes and improved systolic function with cardiac resynchronization therapy: a randomized trial comparing simultaneous biventricular pacing, sequential biventricular pacing, and left ventricular pacing. Circulation 2007;115:2136-2144. Go to original source...
    12. Ritter P, Delnoy P.P, Padeletti L, et al. A randomized pilot study of optimization of cardiac resynchronization therapy in sinus rhythm patients using a peak endocardial acceleration sensor vs. standard methods. Europace 2012;14:1324-1333. Go to original source...
    13. Gasparini M, Bocchiardo M, Lunati M, et al. Comparison of 1-year effects of left ventricular and biventricular pacing in patients with heart failure who have ventricular arrhythmias and left bundle branch block: the Bi vs. Left Ventricular Pacing: an International Pilot Evaluation on Heart Failure Patients with Ventricular Arrhythmias (BELIEVE) multicenter prospective randomized pilot study. Am Heart J 2006;152:155 e151-e157. Go to original source...
    14. Abraham WT, Fisher WG, Smith AL, et al. Cardiac resynchronization in chronic heart failure. N Engl J Med 2002;346:1845-1853. Go to original source...
    15. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338. Go to original source...
    16. Bax JJ, Abraham T, Barold SS, et al. Cardiac resynchronization therapy: part 2. JACC 2005;46:2168-2262. Go to original source...
    17. Glikson M, Nielsen JC, Kronborg MB, et al. 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Developed by the Task Force on cardiac pacing and cardiac resynchronization therapy of the European Society of Cardiology (ESC). With the special contribution of the European Heart Rhythm Association (EHRA). Eur Heart J 2021;42:3427-3520. Go to original source...
    18. Bristow MR, Saxon LA, Boehmer J, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med 2004;350:21402150. Go to original source...
    19. Cleland JG, Daubert JC, Erdmann E, et al. The effect of cardiac resynchronization on morbidity and mortality in heart failure. N Engl J Med 2005;352:1539-1549. Go to original source...
    20. Moss AJ, Hall WJ, Cannom DS, et al. Cardiac-resynchronization therapy for the prevention of heart-failure events. N Engl J Med 2009;361:1329-1338. Go to original source...
    21. Tang AS, Wells GA, Talajic M, et al. Cardiac-resynchronization therapy for mild-to-moderate heart failure. N Engl J Med 2010;363:2385-2395. Go to original source...
    22. Poole JE, Singh JP, Birgersdotter-Green U. QRS Duration or QRS Morphology: What Really Matters in Cardiac Resynchronization Therapy? JACC 2016;67:1104-1117. Go to original source...
    23. Muto C, Solimene F, Gallo P, et al. A randomized study of cardiac resynchronization therapy defibrillator versus dual-chamber implantable cardioverter-defibrillator in ischemic cardiomyopathy with narrow QRS: the NARROW-CRT study. Circ Arrhythm Electrophysiol 2013;6:538-545. Go to original source...
    24. Beshai JF, Grimm RA, Naugueh SF, et al. Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med 2008;357:2461-2471. Go to original source...
    25. Donahue T, Niazi I, Leon A, et al. Acute and chronic response to CRT in narrow QRS patients. J Cardiovasc Transl Res. 2012;5:232-241. Go to original source...
    26. Thibault B, Harel F, Ducharme A, et al. Cardiac resynchronization therapy in patients with heart failure and QRS complex < 120 milliseconds: the Evaluation of Resynchronization Therapy for Heart Failure (LESSER-EARTH) trial. Circulation 2013;127:873-881. Go to original source...
    27. Ruschitzka F, Abraham WT, Singh JP, at al. Cardiac-resynchronization therapy in heart failure with narrow QRS complex. N Eng J Med 2013;369:1395-1405. Go to original source...
    28. Egoavil CA, Ho RT, Greenspon AJ, et al. Cardiac resynchronization therapy in patients with right bundle branch block: analysis of pooled data from the MIRACLE and CONTAK CD trials. Heart Rhythm 2005;2:611-615. Go to original source...
    29. Nery PB, Ha AC, Keren A, et al. Cardiac resynchronization therapy in patients with left systematic ventricular systolic dysfunction and right bundle branch block: a review. Heart Rhythm 2011;8:1083-1087. Go to original source...
    30. Linde C, Abraham WT, Gold MR, et al. Randomized trial of cardiac resynchronization in mildly symptomatic heart failure patients and in asymptomatic patients with left ventricular dysfunction and previous heart failure symptoms. J Am Coll Cardiol 2008;52:1834-1843. Go to original source...
    31. Auricchio A, Lumens J, Prinzen FW. Does cardiac resynchronization therapy benefit patients with right bundle branch block? Circulation 2014;7:532-542. Go to original source...
    32. Carson P, Anand I, Connor C, et al. Mode of death in advanced heart failure: the Comparison of Medical, Pacing, and Defibrillation Therapies in Heart Failure (COMPANION) trial. J Am Coll Cardiol 2005;46:2329-2334. Go to original source...
    33. Cleland JG, Daubert JC, Erdmann E, et al. Long-term effects of cardiac resynchronization therapy on mortality in heart failure [the CArdiac Resynchronization-Heart Failure (CARE-HF) trial extension phase]. Eur Heart J 2006;27:1928-1932. Go to original source...
    34. Al-Majed NS, McAlister FA, Bakal JA, et al. Meta-analysis: cardiac resynchronization therapy for patients with less symptomatic heart failure. Ann Intern Med 2011;154:401-412. Go to original source...
    35. Lam SK, Owen A. Combined resynchronization and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomized controlled trials. BMJ 2007;335:925. Go to original source...
    36. Woods B, Hawkins N, Mealing S, et al. Individual patient data network meta-analysis of mortality effects of implantable cardiac devices. Heart 2015;101:1800-1806. Go to original source...
    37. Kutyifa V, Geller L, Bogyi P, et al. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of high-volume, single-centre experience. Eur J Heart Fail 2014;16:1323-1330. Go to original source...
    38. Barra S, Boveda S, Providencia R, et al. Adding defibrillation therapy to cardiac resynchronization on the basis of the myocardial substrate. J Am Coll Cardiol 2017;69:1669-1678. Go to original source...
    39. Leyva F, Zegard A, Umar F, et al. Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy. Europace 2018;20:1804-1812. Go to original source...
    40. Kober L, Thune JJ, Nielsen JC, et al. Defibrillator implantation in patients with nonischemic systolic heart failure. N Eng J Med 2016;375:1221-1230. Go to original source...
    41. Gras M, Bisson A, Bodin A, et al. Mortality and cardiac resynchronization therapy with or without defibrillation in primary prevention. Europace 2020;22:1224-1223. Go to original source...
    42. Brignole M, Auricchio A, Baron -Esquivias G, et al. ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. The Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013;150:1-49.
    43. Chung ES, Leon AR, Tavazzi L, et al. Results of the Predictors of Response to CRT (PROSPECT) trial. Circulation. 2008;117:2608-2616. Go to original source...
    44. Leya F, Foley PWX, Chalil S, et. al. Female Gender is associated with Better Outcome after Cardiac Resynchronization Therapy. Pacing Clin Electrophysiol 2011;34:82-88. Go to original source...
    45. Loring Z, Canos DA, Selzman K, et al. Left bundle branch block predicts better survival in women than men receiving cardiac resynchronization Therapy. Long-Term Follow-IP of w145,000 Patients. J Am Coll Cardiol 2013;1:237-244. Go to original source...
    46. Rosman J, Dhillon S, Mayer A, et al. Non-ischemic cardiomyopathy patients derive superior mortality benefit from cardiac resynchronization therapy. Indian Pacing Electrophysiol 2007;7:215-217.
    47. Adelstein EC, Tanaka H, Soman P, et al. Impact of scar burden by single-photon emission computed tomography myocardial perfusion imaging on patient outcomes following cardiac resynchronization therapy. Eur Heart J 2011;32:93-103. Go to original source...
    48. van der Bijl P, Khidir M, Ajmone Marsan N, et al. Effect of functional mitral regurgitation on outcome in patients receiving cardiac resynchronization therapy for heart failure. Am J Cardiol 2019;123:75-83. Go to original source...
    49. Leong DP, Hoke U, Delgado V, et al. Right ventricular function and survival following cardiac resynchronization therapy. Heart 2013;99:722-728. Go to original source...

    Return to the content